PLK1 and cancer: These observations suggest that cancer cells are addicted not only to oncogenic RAS or the inactivated p53 function, as Bernard Weinstein originally proposed (Weinstein 2002), but also to non-oncogenic Plk1, whose inhibition results in prometaphase accumulation and subsequent death (Luo et al. 2009b) (Fig. 2).